UOC
IMUX icon

UBS O'Connor’s Immunic IMUX Stock Holding History

UBS O'Connor’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,000
Closed -$20.9K – 360
2025
Q2 		$20.9K Sell
3,000
-1,887
-39% -$17.3K ﹤0.01% 341
2025
Q1 		$53.3K Sell
4,887
-15,571
-76% -$168K ﹤0.01% 282
2024
Q4 		$205K Buy
20,458
+9,689
+90% +$122K 0.01% 330
2024
Q3 		$178K Sell
10,769
-1,000
-8% -$14.2K ﹤0.01% 394
2024
Q2 		$131K Sell
11,769
-5,000
-30% -$62.1K ﹤0.01% 424
2024
Q1 		$221K Sell
16,769
-43,254
-72% -$562K 0.01% 391
2023
Q4 		$900K Sell
60,023
-16,146
-21% -$198K 0.03% 282
2023
Q3 		$1.12M Sell
76,169
-3,000
-4% -$57.7K 0.02% 319
2023
Q2 		$1.99M Buy
79,169
+10,556
+15% +$177K 0.04% 293
2023
Q1 		$1.02M Buy
68,613
+13,624
+25% +$253K 0.02% 399
2022
Q4 		$770K Buy
54,989
+35,190
+178% +$960K 0.01% 591
2022
Q3 		$626K Sell
19,799
-3,460
-15% -$145K 0.01% 792
2022
Q2 		$807K Buy
23,259
+13,259
+133% +$850K 0.01% 785
2022
Q1 		$1.13M Buy
+10,000
New +$1.16M 0.01% 677
2017
Q3 		– Sell
-470
Closed -$545K – 393
2017
Q2 		$545K Sell
470
-30
-6% -$40K 0.01% 337
2017
Q1 		$800K Buy
+500
New +$915K 0.01% 348
2015
Q2 		– Sell
-75
Closed -$750K – 860
2015
Q1 		$750K Buy
75
+50
+200% +$460K 0.01% 588
2014
Q4 		$249K Buy
+25
New +$193K ﹤0.01% 579

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS O'Connor's IMUX Position: Q3 2025 in Review

UBS O'Connor sold out of Immunic (IMUX) in Q3 2025, closing a stake of 3,000 shares — an estimated $20.9K sold.

UBS O'Connor first reported a position in IMUX in Q4 2014 and held it in 18 quarters. The position peaked at $1.99M in Q2 2023. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

  • UBS O'Connor reported no remaining Immunic position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 3,000 Immunic shares in Q3 2025, an estimated $20.9K.
  • UBS O'Connor first reported a position in Immunic in Q4 2014 and held it in 18 quarters.
  • UBS O'Connor's Immunic position peaked at $1.99M in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.